Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels, and vitamin status in women with a history of preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 184, Issue 3, 2001, Pages 394-402

  Lachmeijer, Augusta M A ^a,b,c,d   Arngrímsson, Reynir ^a,b,c,d   Bastiaans, Esther J ^a,b,c,d   Pals, Gerard ^a,b,c,d   Ten Kate, Leo P ^a,b,c,d   De Vries, Johanna I P ^a,b,c,d   Kostense, Pieter J ^a,b,c,d   Aarnoudse, Jan G ^a,b,c,d   Dekker, Guustaaf A ^a,b,c,d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Department of Clinical Epidemiology and Biostatistics ^*  (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d University Hospital   (Netherlands)

Author keywords

Genetics; Hyperhomocysteinemia; Methylenetetrahydrofolate reductase; Mutations; Preeclampsia; Vitamins

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; ENZYME ACTIVITY; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HISTORY; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; METHYLATION; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

EID: 0035089763     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2001.109393     Document Type: Article

References (25)

1. Heterogeneous causes constituting the single syndrome of preeclampsia: A hypothesis and its implications
2. Dyslipidemia, iron, and oxidative stress in preeclampsia: Assessment of maternal and feto-placental interactions
3. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in preeclampsia
4. Homocysteine and vascular disease
5. Underlying disorders associated with severe early-onset preeclampsia
6. Methylenetetrahydrofolate reductase polymorphism and preeclampsia
7. Factor V Leiden, C → T MTHFR polymorphism and genetic susceptibility to preeclampsia
8. Increased frequency of genetic thrombophilia in women with complications of pregnancy
9. Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease
10. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
11. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
12. Decreased methylene-tetrahydrofolate reductase activity due to the 677C→T mutation in families with spina bifida offspring
13. A second common mutation in the methylenete-trahydrofolate reductase gene: An additional risk factor for neural-tube defects?
14. The natural history of homocystinuria due to cystathionine beta-synthase deficiency
15. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum
16. Fasting or post-methionine load homocysteine: Which should be measured in relation to vascular risk?
17. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies
18. On estimating the relationship between blood group and disease
19. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia
20. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease
21. 12 and on the risk of premature atherosclerosis
22. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis
23. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells
24. Plasma homocysteine levels related to interactions between folate status and methylenetetrahydrofolate reductase: A study in 52 healthy subjects
25. 6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction